Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BNP Paribas

Investor type Investment Bank

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 62
Average round size
info
The average size of a deal this fund participated in
$327M
Portfolio companies 57
Rounds per year 1.11
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.08
Exits 15
Key employees 85

Areas of investment

  • Financial Services
  • Software
  • Information Technology
  • Health Care
  • FinTech
Summary

BNP Paribas is the famous Corporate Investor, which was founded in 1966. The main department of described Corporate Investor is located in the Paris. The venture was found in Europe in France.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the BNP Paribas, startups are often financed by Sofinnova Partners, Omnes Capital, Innovation Nest. The meaningful sponsors for the fund in investment in the same round are Bpifrance, Valquest Partners, Sparkling Partners.

Among the most popular portfolio startups of the fund, we may highlight Equisense. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Analytics, Computer. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2019. The fund is generally included in less than 2 deals every year.

The overall number of key employees were 84.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BNP Paribas:
Typical Co-investors
BNP Paribas is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BNP Paribas:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Autenti

Information Services
Information Technology
Internet
Software
$10M13 Sep 2022 Poznań, Greater Poland Voivodeship, Poland

Q-Cells

Electronics
Energy
Solar
$150M08 Sep 2022 Germany, Saxony-Anhalt, Germany

Adani Enterprises

Energy
Manufacturing
Renewable Energy
Solar
$5B31 Jul 2022 Ahmedabad, Gujarat, India

Contentsquare

Analytics
CRM
E-Commerce
SaaS
Sales Automation
$200M20 Jul 2022 Paris, Ile-de-France, France

Sonovate

B2B
Finance
Financial Services
FinTech
Funding Platform
Information Technology
Payments
SaaS
$226M06 Jul 2022 London, England, United Kingdom

Nature Metrics

Biotechnology
Life Science
$16M26 May 2022 Egham, Surrey, United Kingdom

ORPEA

Health Care
Hospital
Hospitality
$2B13 May 2022 Puteaux, Ile-de-France, France

HR Path

Consulting
Human Resources
Software
$265M11 May 2022 Paris, Ile-de-France, France

Saphyre

Asset Management
Financial Services
FinTech
$18M22 Mar 2022 Hoboken, New Jersey, United States
News
Provepharm Life Solution Raises €120M in Funding

– Provepharm Life Solutions, a Marseille-based pharmaceutical company that finds new applications for known molecules.
– The company raised €120M in funding.
Tikehau Capital will provide the funds joining the group’s pool of banking investors, including Société Générale, BNP Paribas, Banque Populaire Méditerranée, Crédit Agricole Alpes Provence and Bpifrance.
– The new investment will be used to consolidate its position as an international and independent pharmaceutical group, specifically by hiring new staff in France and the United States, and increasing the size of its laboratories in Marseille.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BNP Paribas?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: